Healthcare -
Biotechnology - NASDAQ - US
$ 11.17
-1.97 %
$ 552 M
Market Cap
-3.04
P/E
KALV - COST OF REVENUE
Cost of Revenue KALV - KalVista Pharmaceuticals, Inc.
86.2 M
LAST VALUE
976.90%
2 YEAR CAGR
376.65%
5 YEAR CAGR
0.00%
10 YEAR CAGR